Antonio Bertolotto

Implications of neutralising antibodies on therapeutic efficacy.

Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis.

Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.

CD19 mRNA quantification improves rituximab treatment-to-target approach: a proof of concept study.

Biological monitoring of IFN-β therapy in Multiple Sclerosis.

Evaluation of the impact of neutralizing antibodies on IFNβ response.

The use of the 25 Sprotte needle markedly reduces post-dural puncture headache in routine neurological practice.

Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.

Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.

Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.

Nurr1 reduction influences the onset of chronic EAE in mice.

PML risk stratification using anti-JCV antibody index and L-selectin.

The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial.

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.

Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.

Erratum to: Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.

Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study.

Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients.

Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents.

A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?

Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases.

Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients.

Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients.

The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's Thyroiditis.

Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders.

NURR1 deficiency is associated to ADHD-like phenotypes in mice.

NURR1 Impairment in Multiple Sclerosis.

Acknowledgement to Authors, Referees and Readers 2019.

The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice.

TNFAIP3 Deficiency Affects Monocytes, Monocytes-Derived Cells and Microglia in Mice.

Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies.

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients.

Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation.

Exposure to fine particulate matter (PM) hampers myelin repair in a mouse model of white matter demyelination.

A First Phenotypic and Functional Characterization of Placental Extracellular Vesicles from Women with Multiple Sclerosis.

Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice.

Analysis of the Gadolinium retention in the Experimental Autoimmune Encephalomyelitis (EAE) murine model of Multiple Sclerosis.

Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor.

The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes.

NURR1-deficient mice have age- and sex-specific behavioral phenotypes.

The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of Genes in Microglia Cell Line.

sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients.

Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study.